Abstract 19P
Background
Breast cancer is the commonest cancer among women requires multimodality treatment including adjuvant radiotherapy for better loco regional control. Long term toxicity to heart and lung following chemotherapy especially anthracyclines and Trastuzumab.Deep inspiratory breath-hold technique is a state of art technique for reducing heart doses without compromising target coverage or other organ-at-risk. The technique is based upon the observation that during inspiration, the flattening of the diaphragm and expansion of the lungs pulls the heart away from the chest wall. Surface guided radiotherapy (SGRT) is a magnificent devise helps us to do deliver and monitor radiotherapy with DIBH technique easily. This study explores the benefit of using DIBH with SGRT in left sided breast cancer radiotherapy treatment.
Methods
Eighty four breast cancer patients (both BCS and MRM), received adjuvant radiotherapy, between December 2019 and February 2022 were studied in this study. Patients were immobilized using breast boards with both arms positioned above the head. All patients had 2 sets of planning CT images (one in FB and another in DIBH) with a HD CT scanner in the same positional setup.Doses to the target and OARs and patient’s positional shits with three point laser and Align RT (VisionRT) surface guided RT were compared. The standard fractionation regimen of 50Gy in 25 fractions over a period of 5 weeks was used for all patients in this study.
Results
Among Eighty-four enrolled patients, average Dmean, V5%, V10%, V30% to heart with DIBH is 6.27 Gy, 33.04 GY, 19.49 Gy, 3.85Gy respectively. Average Dmean, V5%, V10%, V30% to heart with free breathing is 8.87Gy, 42.2 Gy, 29.9 Gy, 4.9Gy. which shows a statistically significant reduction in dose delivered to heart by using DIBH technique. Average dose to lung in terms of V30 Gy, V20Gy, V12Gy, V5Gy with DIBH is observed to be 24.38%, 28.9%, 36.51%, 48.98% respectively. While using FB technique lung doses in terms of V30 Gy, V20Gy, V12Gy, V5Gy with DIBH is observed to be 27.86%, 32.74, 37.58, 49.45 respectively.
Conclusions
Surface guided radiotherapy helps in precise positioning and patient monitoring which aims at more accurate treatment delivery.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Institutional Review Board.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
29P - Targeting CXCR4 promotes antitumor immunity through TOX-mediated CD8+ T cell activation
Presenter: Canhui Cao
Session: Poster viewing 01
30P - Investigation of KRAS G12C inhibitor JAB-21822 as a single agent and in combination with SHP2 inhibitor JAB-3312 in preclinical cancer models
Presenter: Peng Wang
Session: Poster viewing 01
31P - Photothermal responsive, nucleolin-targeted bimetallic nano-vehicle delivered the combinational therapeutics for improved pancreatic cancer treatment
Presenter: Kandasamy Saravanakumar
Session: Poster viewing 01
32P - Tumor growth inhibition effect of PLAG by regulation of neutrophil infiltration in ICI insensitivity B16F10 melanoma
Presenter: Guen Tae Kim
Session: Poster viewing 01
33P - Establishment of personalized therapeutic for salivary gland cancers based on patients-derived salivary tumoroid model
Presenter: Yoonjin Roh
Session: Poster viewing 01
34P - Association of ACRBP gene polymorphism (+26A/G) to liver cancer and diabetes leads to novel biomarker discovery
Presenter: Md Shariful Islam
Session: Poster viewing 01
35P - Exploring plerixafor as a vector molecule in nuclear medicine for targeting CXCR4 receptor overexpression in vivo
Presenter: Tamanna Lakhanpal
Session: Poster viewing 01
36P - Preclinical evaluation of novel MCL-1 degrader in in vitro and in vivo cancer models
Presenter: Piotr Kowalczyk
Session: Poster viewing 01
37P - Development of splice switching antisense oligonucleotides targeting midkine
Presenter: Graham Robertson
Session: Poster viewing 01
38P - Hormonal modulation of photodynamic therapy efficacy in breast cancer 3D spheroid culture model
Presenter: MN Leung
Session: Poster viewing 01